| # | Title | Journal | Year | Citations |
|---|
| 1 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing | Nature Genetics | 2019 | 1,962 |
| 2 | Diagnosing Schizophrenia in the Initial Prodromal Phase | Archives of General Psychiatry | 2001 | 944 |
| 3 | Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia | Translational Psychiatry | 2012 | 787 |
| 4 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | Nature Genetics | 2017 | 783 |
| 5 | New insights into the genetic etiology of Alzheimer’s disease and related dementias | Nature Genetics | 2022 | 700 |
| 6 | Prediction of Psychosis in Adolescents and Young Adults at High Risk | Archives of General Psychiatry | 2010 | 575 |
| 7 | Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function | Nature Communications | 2018 | 484 |
| 8 | The “sense of agency” and its underlying cognitive and neural mechanisms | Consciousness and Cognition | 2008 | 429 |
| 9 | Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms | Neuropsychopharmacology | 2004 | 423 |
| 10 | Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies | Patient Education and Counseling | 2003 | 414 |
| 11 | EPA guidance on the early intervention in clinical high risk states of psychoses | European Psychiatry | 2015 | 390 |
| 12 | Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients | Annals of Neurology | 2003 | 336 |
| 13 | EPA guidance on the early detection of clinical high risk states of psychoses | European Psychiatry | 2015 | 318 |
| 14 | Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies | Journal of Alzheimer's Disease | 2015 | 317 |
| 15 | Genome-wide association study of obsessive-compulsive disorder | Molecular Psychiatry | 2013 | 312 |
| 16 | Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response | PLoS ONE | 2015 | 293 |
| 17 | Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year | Clinical Neurology and Neurosurgery | 2010 | 287 |
| 18 | Prediction of Psychosis by Mismatch Negativity | Biological Psychiatry | 2011 | 273 |
| 19 | Prepulse inhibition in psychiatric disorders – Apart from schizophrenia | Journal of Psychiatric Research | 2013 | 272 |
| 20 | Subjective Symptoms of Schizophrenia in Research and the Clinic: The Basic Symptom Concept | Schizophrenia Bulletin | 2009 | 261 |
| 21 | Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? | Journal of Neurology, Neurosurgery and Psychiatry | 2007 | 256 |
| 22 | Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression | JAMA Psychiatry | 2018 | 251 |
| 23 | Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia | PLoS Medicine | 2006 | 242 |
| 24 | Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin | Molecular Psychiatry | 2007 | 241 |
| 25 | Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture | PLoS Genetics | 2013 | 241 |
| 26 | Tourette syndrome deep brain stimulation: A review and updated recommendations | Movement Disorders | 2015 | 236 |
| 27 | Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis | British Journal of Psychiatry | 2015 | 226 |
| 28 | Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use | Schizophrenia Research | 2007 | 219 |
| 29 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry | World Journal of Biological Psychiatry | 2018 | 215 |
| 30 | Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia | Molecular Psychiatry | 2015 | 214 |
| 31 | Sensory Gating in Schizophrenia: P50 and N100 Gating in Antipsychotic-Free Subjects at Risk, First-Episode, and Chronic Patients | Biological Psychiatry | 2008 | 212 |
| 32 | At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction | World Psychiatry | 2015 | 209 |
| 33 | Antibodies to infectious agents in individuals with recent onset schizophrenia | European Archives of Psychiatry and Clinical Neuroscience | 2004 | 201 |
| 34 | Connectivity Profile Predictive of Effective Deep Brain Stimulation in Obsessive-Compulsive Disorder | Biological Psychiatry | 2019 | 200 |
| 35 | A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder | Nature Communications | 2020 | 199 |
| 36 | Preventing progression to first-episode psychosis in early initial prodromal states | British Journal of Psychiatry | 2012 | 196 |
| 37 | Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate | Brain and Development | 2007 | 189 |
| 38 | Identification of a biological signature for schizophrenia in serum | Molecular Psychiatry | 2012 | 189 |
| 39 | Basic Symptoms and Ultrahigh Risk Criteria: Symptom Development in the Initial Prodromal State | Schizophrenia Bulletin | 2010 | 186 |
| 40 | Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome | JAMA Neurology | 2018 | 186 |
| 41 | Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome | Journal of Neurology | 2007 | 185 |
| 42 | Deep Brain Stimulation for Tourette-Syndrome: A Systematic Review and Meta-Analysis | Brain Stimulation | 2016 | 185 |
| 43 | Early detection and secondary prevention of psychosis: facts and visions* | European Archives of Psychiatry and Clinical Neuroscience | 2004 | 183 |
| 44 | The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis | Schizophrenia Bulletin | 2016 | 183 |
| 45 | Cannabis and psychiatric disorders: it is not only addiction | Addiction Biology | 2008 | 179 |
| 46 | PRECLINICAL STUDY: Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats | Addiction Biology | 2008 | 176 |
| 47 | Neurocognitive indicators for a conversion to psychosis: Comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis | Schizophrenia Research | 2007 | 175 |
| 48 | Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers | Pharmacopsychiatry | 2005 | 172 |
| 49 | Cannabis, Vulnerability, and the Onset of Schizophrenia: An Epidemiological Perspective | Australian and New Zealand Journal of Psychiatry | 2000 | 167 |
| 50 | Observations on Unaided Smoking Cessation after Deep Brain Stimulation of the Nucleus Accumbens | European Addiction Research | 2009 | 166 |
